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Recently, amniotic fluid has gained attention as one of the potential sources for 
cell therapy and tissue engineering because it has characteristics of multipotent 
stem cells. However, current knowledge about what types of cells are naturally 
found in amniotic fluid is still limited. In this study, we aimed to investigate 
whether human amniotic fluid contains cells that have characteristics of 
respiratory cells. Samples of human amniotic fluid (5mL per sample) obtained from 
amniocenteses were cultured with small airway growth medium (SAGM). Cells were 
grown until the third passage and the presence of type II alveolar cells were 
characterized by inverted microscopy, immunofluorescence, and reverse 
transcription polymerase chain reaction (RT-PCR). On inverted microscopy, 
cultured cells showed typical polygonal and cobblestone-like epithelial morphology. 
The morphology of cells was not changed after selection and passing. 
Immunofluorescence analysis demonstrated that the isolated cells stained positive 
for surfactant protein C (SPC), specific marker for type II alveolar cells. Cells also 
stained positive for TTF-1 protein but negative for CD 31 and vimentin. RT-PCR 
analysis of cells showed expression of SPC mRNA. This study has demonstrated that 
respiratory cells can be isolated and identified from human amniotic fluid cultured 
in SAGM medium. Our results may provide the basis for further investigations of 
amniotic fluid.
Index Words：Amniotic fluid, Respiratory cell, Isolation, Human
INTRODUCTION
Amniotic fluid serves to cushion the 
fetus, protects it from trauma, allows for 
musculoskeletal development, and main-
tains a constant temperature in the womb 
during pregnancy1. It is also used for 
prenatal diagnosis of a wide range of fetal 
abnormalities2,3. In addition to these 
important functions, amniotic fluid has 
gained attention as one of the potential 
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sources for cell therapy and tissue 
engineering because it contains hetero-
geneous populations of fetal cells of all 3 
germ layers4,5. Recently, studies revealing 
that cells isolated from human amniotic 
fluid have characteristics of multipotent 
stem cells have been reported6,7. 
However, although use of human 
amniotic fluid is a well-established and 
popular method in routine prenatal 
diagnosis and human amniotic fluid stem 
cells can be successfully isolated, current 
data about what types of cells are 
naturally found in amniotic fluid are still 
limited4. Previous studies of amniotic fluid 
cell types were usually focused on the 
morphological aspects with limited 
biochemical criteria, not the characteri-
zation of specific cell types2,8,9. Research 
on amniotic fluid stem cells has also 
focused on the isolation of multipotent 
stem cells, not the identification of cells 
found in amniotic fluid6,7,10,11. Identification 
of specific cell types from amniotic fluid 
would be helpful to understand its 
characteristics and guide further inves-
tigations of amniotic fluid.
It would be interesting and important to 
determine which types of cells can be 
isolated and cultured from amniotic fluid. 
In this study, we aimed to investigate 
whether human amniotic fluid contains 
cells that have characteristics of res-
piratory cells.
MATERIALS AND METHODS
1.1 Cell isolation and culture
Ten samples of human amniotic fluid (5 
mL per sample) were obtained from 
amniocenteses that were performed for 
routine prenatal diagnosis at gestational 
ages ranging from 17 to 20 weeks. This 
study was approved by the Institutional 
Review Board of Yonsei University 
College of Medicine (4-2007-0280).
Amniotic fluid samples were centrifuged 
at 2000 rpm for 10 min and cell pellets 
were removed and resuspended in 5 mL of 
Dulbecco’s Modified Eagle Medium (GIBCO, 
Grand Island, NY). Cells were plated on 
collagen type I-coated 60-mm tissue culture 
dishes (IWAKI; Asahi Techno Glass, Japan). 
All cells were fed with small airway 
growth medium (SAGM; BioWhittaker, 
Walkersville, MD) supplemented with 0.5 
mg/mL of bovine serum albumin, 5 µg/mL 
of insulin, 10 µg/mL of transferrin, 30 µg/ 
mL of bovine pituitary extract, 0.5 µg/mL 
of epinephrine, 6.5 ng/mL of triiodo-
thyronine, 0.1 ng/mL of retinoic acid, 0.5
µg/mL of hydrocortisone, and 0.5 ng/mL of 
human epidermal growth factor. Cultures 
were maintained at 37℃ with 5 % CO2  in 
a humidified incubator. Culture medium 
was changed every 3-4 days. After 10-14 
days, cultured cells were observed using 
an Olympus IX 70 inverted microscope, 
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and colonies were selected using cloning 
cylinders (Sigma-Aldrich, St. Louis, MO) 
with 0.25% Trypsin-EDTA (Invitrogen, 
Carlsbad, Canada), and trypsinized cells 
were seeded in collagen type I-coated 
60-mm tissue culture dishes. Cells were 
grown until the third passage and 
analyzed by immunofluorescence analysis 
and RT-PCR. 
1.2 Immunofluorescence analysis 
After the third passages, cells were 
plated on LabTek tissue culture chamber 
slides (Fischer Scientific, Pittsburgh, PA). 
After 2 days of growth, cells were 
washed with PBS and fixed in 4 % 
formaldehyde/PBS for 10 min. Cells were 
incubated in 0.2 % TritonX-100 in PBS for 
10 min on ice, followed by 15% fetal 
bovine serum at room temperature for 10 
min to ensure permeabilization. Cells were 
then incubated overnight at 4℃ with 
primary rabbit polyclonal anti-prosurfactant 
protein C (proSP-C) antibodies (1:100, 
Chemicon, Temecula, CA) and mouse 
monoclonal anti-thyroid transcription factor-1 
(TTF-1) antibodies (1:100, Chemicon) for 
alveolar type II cells, monoclonal anti-
vimentin-Cy3 antibody produced in mouse 
clone V9 (1:50, Sigma) for mesenchymal 
derived cells, and monoclonal anti-CD31 
(PECAM-1)-FITC produced in mouse 
clone WM-59 (1:50, Sigma) for endothelial 
cells. Slides were then incubated with 
Alexa Fluor 594 goat anti-rabbit Ig (1:500, 
Molecular Probes, Eugene, OR) and Alexa 
Fluor 594 goat anti-mouse Ig (1:500, 
Molecular Probes). As positive controls for 
each antibody, A549 cells (ATCC, 
Rockville, MD) for ProSP-C and for 
TTF-1, HUVEC cells (Clonetics, San 
Diego, CA) for CD31, and fibroblast cells 
(from human healthy gingival tissue) for 
vimentin were used. Slides were treated 
with an anti-fade substance (Molecular 
Probes) and observed using Carl Zeiss 
LSM510 confocal laser-scanning microscopy. 
1.3 RT-PCR
Total RNA was isolated from cells 
grown in SAGM after the third passage 
using an RNeasy kit (QIAGEN, Germany), 
and 0.5 µg RNA was reverse-transcribed 
using AMV reverse transcriptase (Promega, 
Madison, WI). The cDNAs were generated 
using random hexamers (Promega) at 45
℃ for 1 hr. Two-step nested RT-PCR 
was employed to amplify SPC mRNA12. 
The first PCR amplification was carried 
out in a 20 µL AccuPower PCR PreMix 
(Bioneer, Korea) containing 100 ng of 
DNA template under the following 
conditions: 5 min hot start at 95℃, 30 
cycles at 95℃ for 30 sec, 57℃ for 30 sec, 
72℃ for 30 sec, and a final extension for 
5 min at 72℃. Twenty pmol of primers 
were used in each reaction. The first PCR 
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Table 1. RT-PCR Primer Sequences and Expected Product Sizes
Gene Primer Sequence Productsize (bp)
SPC
First primer
Forward 5’-AAAGAGGTCCTGATGGAGAGC-3’
Reverse 5’-TAGATGTAGTAGAGCGGCACCT-3’
456
Nested primer
Forward 5’-AACGCCTTCTTATCGTGGTG-3’
Reverse 5’-GTGAGAGCCTCAAGACTGG-3’
313
GAPDH
Forward 5’-GAAGGTGAAGGTCGGAGT-3’
Reverse 5’-GAAGATGGTGATGGGATTTC-3’
226
Table 2. Summary of Cell Isolation, RT-PCR and Immunofluorescence
Sample No. 1 2 3 4 5 6 7 8 9
Cell isolation Yes No No Yes No Yes Yes Yes Yes
Expression of SPC
mRNA on RT-PCR
+ N/A N/A + N/A - + - -
Expression of ProSP-C
and TTF-1 on Immuno-
fluorescence analysis 
+ N/A N/A + N/A - + - +
N/A, not available
product was diluted 1:50 with distilled 
water. One µL of diluted first PCR 
product was used as a template for the 
nested reaction with the same cycling 
conditions and primer concentrations 
outlined above. RT-PCR amplification of 
the housekeeping gene, GAPDH, was used 
to monitor the quality of the mRNA and 
control for the efficiency of the RT step. 
The oligonucleotide primers are described 
in Table 1. The nested PCR products 
were loaded onto 2 % agarose gel and 
visualized by ethidium bromide staining. 
Product sizes were compared to a 100-bp 
molecular size marker. A549 cells were 
used as a positive control for SPC.
RESULTS
Among 10 samples of amniotic fluid, 1 
was discarded because of contamination. 
From 9 samples, 6 had cell colonies and 
the isolation of cells was possible. Positive 
results from RT-PCR and immuno-
fluorescence analysis were obtained in 3 
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Fig. 1. Morphology of cells by inverted 
microscopy (100×). Cultured cells displayed 
a typical polygonal and cobblestone-like 
epithelial appearance.
Fig. 2. RT-PCR of SPC mRNA extracted from cells cultured in SAGM. Lane M, 
100-bp ladder molecular size marker; lane C, control (A549 cell); lanes 1, 4, 7, 
Cells from sample Nos. 1, 4, and 7. Expression of SPC mRNA was markedly 
augmented by nested PCR amplification. The cDNA was obtained from A549 
cells that were used as a positive control and also expressed SPC mRNA. 
(sample No. 1, 4, 7) and 4 (sample No. 1, 
4, 7, 9) of these 6 samples (Table 2).
2.1 Cell culture and isolation
Ten to 14 days after initial plating, 
polygonal and cobblestone-like cells were 
observed with few colony formation. Cell 
morphology did not change after selection 
and passaging (Fig. 1). Selected cells were 
maintained and expanded until the third 
passage but did not reach confluence. 
2.2 RT-PCR
Expression of SPC mRNA was not 
detected in the first PCR reaction but was 
markedly augmented by nested PCR 
amplification. The cDNA obtained from 
A549 cells was used as a positive control 
and also expressed SPC mRNA (Fig. 2).
2.3 Immunofluorescence analysis 
Isolated cells expressed type II alveolar 
cell-specific surfactant protein proSP-C. 
Cells also stained positive for TTF-1, a 
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Fig. 3. Immunofluorescence staining. Isolated cells from different human amniotic fluid 
culture (sample Nos. 1, 4, 7, and 9) expressed SPC (A-D) and TTF-1(F-I) but 
negatively expressed CD31 (K-N) and vimentin (P-S). Positive control cells for SPC and 
TTF-1 (A549 cells; E, J), CD31 (HUVEC cells; O), and vimentin (fibroblast cells; T) 
were clearly positive.
specific marker for type II alveolar cell 
differentiation. However, no cells immuno-
reactive to CD31 or vimentin were 
detected. Positive control cells for each 
antibody were clearly positive (Fig. 3).
DISCUSSION
This study demonstrates that respiratory 
cells could be isolated from human 
amniotic fluid cultivated in SAGM medium 
in vitro. Most of these cells had an 
appearance of epithelial cell-like mor-
phology13,14 and expressed type II alveolar 
cell markers SPC (mRNA and protein) as 
well as TTF-1. To the best of our 
knowledge, this is the first report of the 
successful isolation of respiratory cells 
from human amniotic fluid.
The possibility of amniotic fluid having 
respiratory cells can be speculated because 
amniotic fluid is composed of hetero-
geneous fetal cells including hematopoietic, 
mesenchymal, epithelial, trophoblastic, and 
possibly more primitive stem cells5,15. 
The composition of the amniotic fluid 
cell is thought to be correlated with the 
production and turnover of amniotic fluid. 
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The significant pathways involved in the 
regulation of amniotic fluid are excretion 
of fetal urine, swallowing of amniotic fluid 
and gastrointestinal excretion, secretion of 
fluid by fetal lung, water transport across 
the skin of the fetus, amniotic membrane, 
and fetal vessels in the umbilical cord16. 
As a result of such fluid dynamics, 
different types of cells can be identified in 
amniotic fluid cultures2,9,17. Among them, 
the secretion of large volumes of fluid by 
fetal lung is one of the major sources of 
amniotic fluid, especially during the second 
half of gestation. According to this 
physiology, it could be expected that 
respiratory cells are found in amniotic 
fluid.
Among the various types of respiratory 
cells, type II alveolar cells are responsible 
for surfactant production and are crucial 
to the natural regenerative process of the 
alveoli. In response to injury, type II 
alveolar cells are able to proliferate and 
differentiate to type I alveolar cells and 
are considered to be the alveolar epithelial 
stem cell18,19. In our study, the identi-
fication of type II alveolar cells is based 
on amplification of SPC mRNA by 
RT-PCR and the presence of Pro-SPC 
and TTF-1 by immunofluorescence 
staining. SPC is an integral membrane 
protein that is expressed only in type II 
alveolar cells and is known to be a 
specific marker for type II alveolar 
cells20,21. TTF-1 is essential for branching 
morphogenesis of the lung and enhances 
expression of surfactant proteins by type 
II alveolar cells22. Identification of SPC 
and its corresponding mRNA and of 
TTF-1 serves to confirm the presence of 
type II alveolar cells. 
Type II alveolar cells are difficult to 
culture in vitro because of their low rate 
of division and tendency to differentiate 
into type I alveolar cells23. In this study, 
we chose a serum-free medium designed 
for in vitro maintenance of mature 
alveolar epithelial cells, SAGM medium, 
from among the few published des-
criptions of type II alveolar cell culture 
techniques24-27. This medium contains 
factors known to enhance respiratory cell 
differentiation and has been successfully 
used in previous studies of type II 
alveolar cell cultures from different cell 
sources12,14. However, the effectiveness of 
SAGM has not been fully evaluated and a 
recent study reported conflicting effects of 
SAGM28. Cell yield of our study was low, 
and further investigations of cell culture 
methods are required to get a sufficient 
number of type II alveolar cells.
Recent experimental research suggests 
that amniotic fluid is a potential source of 
stem cells. These studies successfully 
demonstrated that human amniotic fluid 
stem cells can be differentiated into 
specialized cell populations such as neural, 
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hepatic, osteogenic, renal, and lung 
epithelial lineages6,7,10,11. However, those 
studies were mainly concentrated on the 
isolation and differentiation of amniotic 
fluid stem cells with limited supportive 
data rather than what types of cells are 
normally found in amniotic fluid. Iden-
tification of specific cell types of amniotic 
fluid would be important in understanding 
the characteristics of amniotic fluid.
In conclusion, we have shown that 
respiratory cells can be isolated and 
identified from human amniotic fluid 
cultured in SAGM medium. Our results 
may provide the basis for further 
investigations.
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사람 양수에서 호흡기세포의 분리
연세대학교 의과대학 외과학교실1, 산부인과학교실2, 장기이식연구소3
김은정1․박용원2․김영한2․김유선1,3․오정탁1
최근에 양수에 존재하는 세포들은 다양한 세포분화의 능력을 가지고 있으며 세포 치료와 조직공
학의 세포원으로서의 가능성이 높다는 연구 결과가 많이 보고되고 있다. 그러나 양수 내에 어떤 종
류의 세포가 정상적으로 존재하는 지에 대해서는 제한적으로 알려져 있다. 본 연구에서는 사람의 
양수 내에 호흡기세포를 분리 배양하는 것을 목표로 하였다.
임신 17주에서 20주 사이의 산모 10명에서 각각 5mL의 양수를 획득하여 small airway growth 
medium (SAGM) 배양액에서 계대 배양을 시행하였으며 type II alveolar cells이 존재하는 지에 대
하여 면역형광염색 및 RT-PCR을 시행하였다. 배양된 세포는 광학현미경 상 상피세포와 유사한 다
면체의 모양이었으며 계대 배양 시에 변화 없이 동일한 형체를 보였다. 배양된 세포는 면역형광염
색 상 type II alveolar cell의 특이표지자인 surfactant protein C (SPC) 및 TTF-1 protein에 대해
서는 양성이었으나 CD 31 및 vimentin에 대해서는 음성이었으며, RT-PCR 상 SPC mRNA 가 발
현되었다. 
이상의 결과로 사람의 양수를 특이 배양액에 배양하면 호흡기세포를 분리, 확인할 수 있음을 알
았으며 이러한 결과가 향후 양수세포의 추가적인 연구에 활용될 수 있다고 생각된다. 
(J Kor Assoc Pediatr Surg 15(1):1～10), 2009.
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